Equity Analysis

Quarterly Results

    FDC Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    531599
    INE258B01022
    121.05335
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    FDC
    24.68
    7308.54
    EPS(TTM)
    Face Value()
    Div & Yield %:
    18.19
    1
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales452.22479.70530.04
Other Operating Income0.000.000.00
Other Income 25.3327.3929.78
Total Income477.55507.08559.82
Total Expenditure 370.31400.99410.03
PBIDT107.23106.10149.79
Interest 0.971.051.04
PBDT106.27105.05148.75
Depreciation9.939.819.59
Tax20.4021.5230.50
Fringe Benefit Tax0.000.000.00
Deferred Tax-2.441.670.11
Reported Profit After Tax78.3872.04108.55
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item78.3872.04108.55
EPS (Unit Curr.)4.814.366.54
EPS (Adj) (Unit Curr.)4.814.366.54
Calculated EPS (Unit Curr.)4.814.426.54
Calculated EPS (Adj) (Unit Curr.)4.814.426.54
Calculated EPS (Ann.) (Unit Curr.)19.2617.7026.17
Calculated EPS (Adj) (Ann.) (Unit Curr.)19.2617.7026.17
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity16.2816.2816.59
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)23.7122.1228.26
PBDTM(%)23.5021.9028.06
PATM(%)17.3315.0220.48
Dividend Per Share(Rs)0.000.000.00
Diluted EPS4.814.366.54